Ambry Genetics is a company within the Biotechnology category. Ambry Genetics is a clinical laboratory and healthcare company specialized in genetic testing and diagnostic services. It provides various screening tools for hereditary diseases, including cancer, cardiovascular disorders, and neurological conditions, primarily serving healthcare providers and researchers.
Ambry Genetics was founded in 1999 and is headquartered in Aliso Viejo, CA.
Ambry Genetics is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Ambry Genetics is Moderate. Significant factual deltas detected. Inconsistent representation across models.
AI models classify Ambry Genetics as a Challenger. AI names competitors first.
Ambry Genetics appeared in 7 of 8 sampled buyer-intent queries (88%). The brand has high visibility for clinical-specific queries but faces competition from larger general labs on broader diagnostic terms.
AI maintains a strong, clear profile of the brand as an established clinical diagnostic leader. While basic identifying facts are stable, specific product names and the nuances of its corporate relationship with REALM IDx may be less precise. Key gap: Models may still reference Ambry as a standalone entity or part of 'Konica Minolta Precision Medicine' rather than its most recent integration status within the REALM IDx platform.
Of 6 key facts verified about Ambry Genetics, 4 are well-documented (likely accurate across AI models), 2 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Current leadership team and specific executive roles are likely to be outdated in AI responses due to internal restructuring post-acquisition.
Buyers turn to Ambry Genetics for In-hospital Clinical Labs: Traditional pathology labs within hospitals performing manual clinicial coordination., Symptomatic Monitoring Only: Forgoing genetic testing due to cost or lack of access, relying solely on family history and physical symptoms., among 2 documented problem areas.
Buyers evaluating Ambry Genetics typically ask AI models about "hereditary cancer genetic testing labs", "clinical exome sequencing services", "genetic testing for cardiomyopathy", and 3 similar queries.
Ambry Genetics's main competitors are Invitae, Myriad Genetics, Inc., Natera. According to AI models, these are the brands most frequently named alongside Ambry Genetics in buyer-intent queries.
Ambry Genetics's core products are Genetic testing panels (CancerNext, CardioNext), whole exome sequencing, RNA sequencing (+RNAinsight)..
Ambry Genetics uses Enterprise/Custom (Insurance-based and institutional billing).
Ambry Genetics serves Oncologists, Genetic Counselors, Health Systems, Research Institutions..
Ambry Genetics First to provide clinical diagnostic NGS and a leader in integrating RNA sequencing with DNA testing to reduce uncertain results.
Brand Authority Index (BAI) tier: Leader (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/ambry-genetics
Last analyzed: April 9, 2026
Founded: 1999
Headquarters: Aliso Viejo, California